The Johnson & Johnson spinoff that makes Tylenol and Benadryl, said Chief Executive Thibaut Mongon has departed and that the company is considering simplifying its portfolio amid a recent sales slump.

The Johnson & Johnson spinoff that makes Tylenol and Benadryl, said Chief Executive Thibaut Mongon has departed and that the company is considering simplifying its portfolio amid a recent sales slump.

Kenvue Inc ousted its chief executive and announced a strategic review on Monday. Jefferies says KVUE shares could rally to ...

US stocks rose on Monday with the Nasdaq closing at a fresh record with Trump's tariffs in focus as key inflation data and ...

If the Blue Jays were going to have real success in 2025, they needed real rebounds. Kirk’s revival is one of many, and he’s heading back to the All-Star game because of it. “After a couple ...

Starting at 4:30 p.m., the 22 large banks that were stress-tested by the Fed can release information about their plans for dividend increases and share repurchases.

And that could put an added emphasis on Starbucks’ ongoing turnaround plans, as Luckin has grown to outnumber that company in China, with 22,000 locations.

J.M. Smucker Co. plans to remove artificial colors from its products by the end of 2027. Orrville, Ohio-based Smucker said Thursday it will also remove synthetic dyes from foods sold to K-12 ...

President Trump's shift from NATO critic to supporter coincides with alliance nations doubling defense spending targets from 2% to 5% of GDP, following years of contentious relations.

Nike Stock Soars 15%: Is This the Real Turnaround (Or Just a Bounce)? June 28, 2025 — 03:33 am EDT Written by Neil Rozenbaum for The Motley Fool -> ...

And Target, as a Dividend King, has a monster of a dividend record and a historically high yield, for investors willing to dip into turnaround stocks.

Nike shares jumped 15% Friday, a day after the athletic apparel giant topped fiscal fourth-quarter estimates.